Liraglutide is one of the best-known GLP-1 molecules in metabolic research. But familiarity can create a sourcing blind spot: knowing the molecule’s name does not prove the identity, purity or consistency of the material in front of you.
For laboratories and B2B buyers sourcing Liraglutide research peptide, analytical verification still matters.
What Is Liraglutide?
Liraglutide (CAS 204656-20-2), also known as NN2211, is a long-acting acylated glucagon-like peptide-1 (GLP-1) analogue.
The molecule was designed with a fatty-acid modification that promotes albumin association and changes its pharmacokinetic behavior compared with native GLP-1.
In research environments, Liraglutide may be used in studies involving:
- GLP-1 receptor signaling;
- incretin biology;
- metabolic pathways;
- peptide-receptor interactions;
- analytical method development;
- formulation research.
Why a Known Molecule Still Needs Identity Testing
Because Liraglutide is well known, buyers may focus only on the headline purity percentage.
That is not enough.
HPLC purity and molecular identity answer different questions.
A sample can display a dominant HPLC peak without that result independently proving the exact expected molecular structure.
Professional buyers should consider verifying:
- molecular identity;
- molecular weight;
- peptide specification;
- chromatographic purity;
- related impurities;
- batch consistency.
For modified peptides such as Liraglutide, this distinction becomes especially important.
What Do Liraglutide Reviews Say?
Online experiences are mixed.
Some users report perceived effects involving:
- reduced appetite;
- earlier satiety;
- changes in food intake;
- body-weight reduction.
Others report little noticeable effect.
Negative experiences commonly discussed online include:
- nausea;
- vomiting;
- constipation;
- diarrhea;
- fatigue;
- headache;
- dizziness.
These reviews should not be used to evaluate a particular research-grade batch.
The exact formulation, source, purity, concurrent medications, medical history and other variables are usually unknown.
For professional procurement, analytical documentation is more useful than testimonials.
Choosing a Liraglutide Supplier: What Should B2B Buyers Verify?
1. Confirm Molecular Identity
The material should be clearly identified as:
Liraglutide / NN2211 / GLP-1 analogue
with molecular specifications matching the expected compound.
2. Review HPLC Purity
Liraglutide HPLC analysis can provide information about chromatographic purity and related impurities.
But a high HPLC result should not be treated as complete structural confirmation.
3. Review MS or LC-MS Data
Where available, Liraglutide MS or LC-MS data can provide additional evidence supporting molecular identity.
For professional research procurement, identity and purity should be evaluated together.
4. Request a Batch-Specific COA
A useful Liraglutide Certificate of Analysis should correspond to the actual production lot.
Depending on the application, B2B buyers may consider reviewing:
- HPLC purity;
- MS or LC-MS identity;
- molecular weight;
- lot number;
- product specifications;
- SDS;
- storage conditions;
- applicable impurity information.
Liraglutide Research Peptide from Sunone
Sunone (Hong Kong) Biopharmaceutical International Technology Co., Limited supplies Liraglutide for qualified laboratory research, analytical development and biopharmaceutical manufacturing applications.
Current product information includes:
Product: Liraglutide
Synonym: NN2211 / GLP-1 Analog
CAS: 204656-20-2
Molecular Formula: C172H265N43O51
Molecular Weight: 3751.2 g/mol
Grade: Research Grade
Purity: ≥98% by HPLC
Form: Lyophilized Peptide
Documentation: COA, SDS, specification sheet and batch analytical data available as applicable
Sunone also supports qualified B2B projects involving customized vial sizes, packaging, labeling and OEM/ODM supply.
Looking for a Liraglutide research peptide supplier with batch-specific analytical documentation?
View Liraglutide Specifications ：
Send Sunone your required quantity, purity specification, packaging format and analytical-documentation requirements to discuss a B2B quotation.
Liraglutide FAQ
What is the CAS number for Liraglutide?
Liraglutide is identified as CAS 204656-20-2.
What is NN2211?
NN2211 is a development name associated with Liraglutide.
Is Liraglutide a GLP-1 analogue?
Yes. Liraglutide is an acylated GLP-1 analogue designed to interact with the GLP-1 receptor.
Does 98% HPLC prove Liraglutide identity?
No. HPLC measures chromatographic purity. Molecular identity generally requires appropriate identity testing such as MS, LC-MS or another validated analytical method.
What should buyers request from a Liraglutide supplier?
Professional buyers may consider requesting a batch-specific COA, HPLC chromatogram, MS/LC-MS identity data, product specification, SDS and lot traceability.
This content is provided for scientific and educational purposes only. SUNONE research peptide is for qualified labrtorynt, diagnois, druc tor mmatct or veteimant, use.research only, Not for human consumption, clinical treame. Purchasers are responsible for complying with applicable laws and regulations in their jurisdiction.
Leave a Reply